Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity.

Journal of the American College of Cardiology2025PMID: 39566870

View on PubMed DOI: 10.1016/j.jacc.2024.11.008

Authors

Verma, Subodh; Emerson, Scott; Plutzky, Jorge; Kahn, Steven E; Stensen, Signe; Weeke, Peter E; Musinga, Derrick; Poirier, Paul; Lingvay, Ildiko; Lincoff, A Michael

Keywords

cardiovascular diseasecoronary artery bypass graftmajor cardiovascular adverse eventobesityoverweight